Astellas Pharma Inc (ALPMY)
9.59
+0.12
(+1.27%)
USD |
OTCM |
Apr 19, 09:37
Astellas Pharma Accounts Payable (Quarterly): 1.067B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.067B |
September 30, 2023 | 985.69M |
June 30, 2023 | 956.06M |
March 31, 2023 | 1.052B |
December 31, 2022 | 1.024B |
September 30, 2022 | 1.014B |
June 30, 2022 | 1.114B |
March 31, 2022 | 1.071B |
December 31, 2021 | 1.190B |
September 30, 2021 | 996.64M |
June 30, 2021 | 981.07M |
March 31, 2021 | 1.131B |
December 31, 2020 | 1.076B |
September 30, 2020 | 1.074B |
June 30, 2020 | 1.233B |
March 31, 2020 | 1.591B |
December 31, 2019 | 1.284B |
September 30, 2019 | 1.485B |
June 30, 2019 | 1.298B |
March 31, 2019 | 1.671B |
December 31, 2018 | 1.737B |
September 30, 2018 | 1.283B |
June 30, 2018 | 1.250B |
March 31, 2018 | 1.326B |
December 31, 2017 | 1.223B |
Date | Value |
---|---|
September 30, 2017 | 1.112B |
June 30, 2017 | 1.363B |
March 31, 2017 | 1.635B |
December 31, 2016 | 1.395B |
September 30, 2016 | 1.523B |
June 30, 2016 | 1.545B |
March 31, 2016 | 1.615B |
December 31, 2015 | 1.653B |
September 30, 2015 | 1.685B |
June 30, 2015 | 1.626B |
March 31, 2015 | 1.888B |
December 31, 2014 | 1.842B |
September 30, 2014 | 1.945B |
June 30, 2014 | 1.828B |
March 31, 2014 | 1.817B |
December 31, 2013 | 1.095B |
September 30, 2013 | 1.108B |
June 30, 2013 | 1.083B |
March 31, 2013 | 2.143B |
December 31, 2012 | 1.345B |
September 30, 2012 | 1.132B |
June 30, 2012 | 1.307B |
March 31, 2012 | 2.421B |
December 31, 2011 | 1.471B |
September 30, 2011 | 1.228B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
956.06M
Minimum
Jun 2023
1.591B
Maximum
Mar 2020
1.138B
Average
1.074B
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Daiichi Sankyo Co Ltd | 3.235B |
Takeda Pharmaceutical Co Ltd | 3.430B |
Nxera Pharma Co Ltd | 30.09M |
PeptiDream Inc | 22.72M |
Stemcell Holdings Inc | 0.4007M |